These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6542777

  • 1. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T, Ogawa K, Watanabe J, Chen LS, Shikano M, Imaizumi M, Shibata T, Ito Y, Miyazaki Y, Satake T.
    Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M.
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract] [Full Text] [Related]

  • 4. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T, Ogawa K, Sakai K, Watanabe J, Satake T, Kayama N, Hiraku S, Naito J.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Sep; 11():245-51. PubMed ID: 6221531
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H, Usui Y, Mita H, Onoda N, Iida M, Okuda C.
    Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Sep; 11():241-4. PubMed ID: 6221530
    [No Abstract] [Full Text] [Related]

  • 13. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T, Nomura T, Ozawa Y, Maeda K, Shibata M.
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract] [Full Text] [Related]

  • 14. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y, Handa H, Okamoto S, Ohta T, Kamijo Y, Oda Y, Kondo A, Nin K, Yamamoto T, Ban S.
    Nihon Geka Hokan; 1986 May 01; 55(3):473-84. PubMed ID: 3541826
    [No Abstract] [Full Text] [Related]

  • 15. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov 01; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 16. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW, Shebuski RJ, Miller OV, Gorman RR.
    J Pharmacol Exp Ther; 1981 Nov 01; 219(2):299-308. PubMed ID: 6270303
    [No Abstract] [Full Text] [Related]

  • 17. Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease.
    Hutton I, Tweddel AC, Rankin AC, Walker ID, Davidson JF.
    Br J Clin Pharmacol; 1983 Nov 01; 15 Suppl 1(Suppl 1):79S-82S. PubMed ID: 6681709
    [Abstract] [Full Text] [Related]

  • 18. Effects of dazoxiben on exercise performance in chronic stable angina.
    Reuben SR, Kuan P, Cairns J, Gyde OH.
    Br J Clin Pharmacol; 1983 Nov 01; 15 Suppl 1(Suppl 1):83S-86S. PubMed ID: 6402000
    [Abstract] [Full Text] [Related]

  • 19. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M, Ito T, Ogawa K, Satake T.
    Jpn Heart J; 1987 Sep 01; 28(5):663-74. PubMed ID: 3323562
    [Abstract] [Full Text] [Related]

  • 20. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J, Thaulow E, Myhre E, Parry J.
    Thromb Haemost; 1983 Oct 31; 50(3):703-6. PubMed ID: 6689091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.